Entrada Therapeutics, Inc.TRDANASDAQ
Loading
Total Costs & Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+23.5%
5Y CAGR+47.0%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
+23.5%/yr
Annual compound
5Y CAGR
+47.0%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
6.9x
Strong expansion
Streak
6 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$183.32M+11.9%
2024$163.77M+23.9%
2023$132.18M+35.9%
2022$97.25M+90.2%
2021$51.13M+91.7%
2020$26.67M+125.5%
2019$11.82M-